TY - JOUR AU - Ostrom, Q. T. AU - Gittleman, H. AU - Fulop, J. AU - Liu, M. AU - Blanda, R. AU - Kromer, C. PY - 2015 DA - 2015// TI - CBTRUS Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012 JO - Neuro-Oncol VL - 17 UR - https://doi.org/10.1093/neuonc/nov189 DO - 10.1093/neuonc/nov189 ID - Ostrom2015 ER - TY - JOUR AU - Lamborn, K. R. AU - Yung, W. K. A. AU - Chang, S. M. AU - Wen, P. Y. AU - Cloughesy, T. F. AU - DeAngelis, L. M. PY - 2008 DA - 2008// TI - Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas JO - Neuro-Oncol. VL - 10 UR - https://doi.org/10.1215/15228517-2007-062 DO - 10.1215/15228517-2007-062 ID - Lamborn2008 ER - TY - JOUR AU - Albert, N. L. AU - Weller, M. AU - Suchorska, B. AU - Galldiks, N. AU - Soffietti, R. AU - Kim, M. M. PY - 2016 DA - 2016// TI - Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas JO - Neuro-Oncol. VL - 18 UR - https://doi.org/10.1093/neuonc/now058 DO - 10.1093/neuonc/now058 ID - Albert2016 ER - TY - JOUR AU - Law, I. AU - Albert, N. L. AU - Arbizu, J. AU - Boellaard, R. AU - Drzezga, A. AU - Galldiks, N. PY - 2019 DA - 2019// TI - Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 JO - Eur J Nucl Med Mol Imaging VL - 46 UR - https://doi.org/10.1007/s00259-018-4207-9 DO - 10.1007/s00259-018-4207-9 ID - Law2019 ER - TY - JOUR AU - Chen, W. AU - Silverman, D. H. S. AU - Delaloye, S. AU - Czernin, J. AU - Kamdar, N. AU - Pope, W. PY - 2006 DA - 2006// TI - 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy JO - J Nucl Med VL - 47 ID - Chen2006 ER - TY - JOUR AU - Fueger, B. J. AU - Czernin, J. AU - Cloughesy, T. AU - Silverman, D. H. AU - Geist, C. L. AU - Walter, M. A. PY - 2010 DA - 2010// TI - Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.110.078592 DO - 10.2967/jnumed.110.078592 ID - Fueger2010 ER - TY - JOUR AU - Janvier, L. AU - Olivier, P. AU - Blonski, M. AU - Morel, O. AU - Vignaud, J. -. M. AU - Karcher, G. PY - 2015 DA - 2015// TI - Correlation of SUV-derived indices with tumoral aggressiveness of gliomas in static 18F-FDOPA PET: use in clinical practice JO - Clin Nucl Med VL - 40 UR - https://doi.org/10.1097/RLU.0000000000000897 DO - 10.1097/RLU.0000000000000897 ID - Janvier2015 ER - TY - JOUR AU - Herrmann, K. AU - Czernin, J. AU - Cloughesy, T. AU - Lai, A. AU - Pomykala, K. L. AU - Benz, M. R. PY - 2014 DA - 2014// TI - Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients JO - Neuro-Oncol. VL - 16 UR - https://doi.org/10.1093/neuonc/not166 DO - 10.1093/neuonc/not166 ID - Herrmann2014 ER - TY - JOUR AU - Youland, R. S. AU - Pafundi, D. H. AU - Brinkmann, D. H. AU - Lowe, V. J. AU - Morris, J. M. AU - Kemp, B. J. PY - 2018 DA - 2018// TI - Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas JO - J Neuro-Oncol VL - 137 UR - https://doi.org/10.1007/s11060-018-2750-7 DO - 10.1007/s11060-018-2750-7 ID - Youland2018 ER - TY - JOUR AU - Karunanithi, S. AU - Sharma, P. AU - Kumar, A. AU - Khangembam, B. C. AU - Bandopadhyaya, G. P. AU - Kumar, R. PY - 2013 DA - 2013// TI - 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-013-2384-0 DO - 10.1007/s00259-013-2384-0 ID - Karunanithi2013 ER - TY - JOUR AU - Galldiks, N. AU - Stoffels, G. AU - Filss, C. AU - Rapp, M. AU - Blau, T. AU - Tscherpel, C. PY - 2015 DA - 2015// TI - The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma JO - Neuro-Oncol. VL - 17 UR - https://doi.org/10.1093/neuonc/nov118 DO - 10.1093/neuonc/nov118 ID - Galldiks2015 ER - TY - JOUR AU - Verger, A. AU - Filss, C. P. AU - Lohmann, P. AU - Stoffels, G. AU - Sabel, M. AU - Wittsack, H. -. J. PY - 2018 DA - 2018// TI - Comparison of O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography and perfusion-weighted magnetic resonance imaging in the diagnosis of patients with progressive and recurrent glioma: a hybrid positron emission tomography/magnetic resonance study JO - World Neurosurg VL - 113 UR - https://doi.org/10.1016/j.wneu.2018.02.139 DO - 10.1016/j.wneu.2018.02.139 ID - Verger2018 ER - TY - JOUR AU - Pyka, T. AU - Hiob, D. AU - Preibisch, C. AU - Gempt, J. AU - Wiestler, B. AU - Schlegel, J. PY - 2018 DA - 2018// TI - Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI JO - Eur J Radiol VL - 103 UR - https://doi.org/10.1016/j.ejrad.2018.04.003 DO - 10.1016/j.ejrad.2018.04.003 ID - Pyka2018 ER - TY - JOUR AU - Maurer, G. D. AU - Brucker, D. P. AU - Stoffels, G. AU - Filipski, K. AU - Filss, C. P. AU - Mottaghy, F. M. PY - 2020 DA - 2020// TI - 18 F-FET PET imaging in differentiating glioma progression from treatment-related changes – a single-center experience JO - J Nucl Med VL - 61 UR - https://doi.org/10.2967/jnumed.119.234757 DO - 10.2967/jnumed.119.234757 ID - Maurer2020 ER - TY - JOUR AU - Lapa, C. AU - Linsenmann, T. AU - Monoranu, C. M. AU - Samnick, S. AU - Buck, A. K. AU - Bluemel, C. PY - 2014 DA - 2014// TI - Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients JO - J Nucl Med Off Publ Soc Nucl Med VL - 55 ID - Lapa2014 ER - TY - JOUR AU - Schiepers, C. AU - Chen, W. AU - Cloughesy, T. AU - Dahlbom, M. AU - Huang, S. -. C. PY - 2007 DA - 2007// TI - 18F-FDOPA kinetics in brain tumors JO - J Nucl Med VL - 48 UR - https://doi.org/10.2967/jnumed.106.039321 DO - 10.2967/jnumed.106.039321 ID - Schiepers2007 ER - TY - STD TI - Ginet M, Zaragori T, Marie P-Y, Roch V, Gauchotte G, Rech F, et al. Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas. Eur J Nucl Med Mol Imaging. 2019. ID - ref17 ER - TY - JOUR AU - Sala, Q. AU - Metellus, P. AU - Taieb, D. AU - Kaphan, E. AU - Figarella-Branger, D. AU - Guedj, E. PY - 2014 DA - 2014// TI - 18F-DOPA, a clinically available PET tracer to study brain inflammation? JO - Clin Nucl Med VL - 39 UR - https://doi.org/10.1097/RLU.0000000000000383 DO - 10.1097/RLU.0000000000000383 ID - Sala2014 ER - TY - JOUR AU - Wen, P. Y. AU - Macdonald, D. R. AU - Reardon, D. A. AU - Cloughesy, T. F. AU - Sorensen, A. G. AU - Galanis, E. PY - 2010 DA - 2010// TI - Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.3541 DO - 10.1200/JCO.2009.26.3541 ID - Wen2010 ER - TY - JOUR AU - Weller, M. AU - Bent, M. AU - Hopkins, K. AU - Tonn, J. C. AU - Stupp, R. AU - Falini, A. PY - 2014 DA - 2014// TI - EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70011-7 DO - 10.1016/S1470-2045(14)70011-7 ID - Weller2014 ER - TY - JOUR AU - Weller, M. AU - Bent, M. AU - Tonn, J. C. AU - Stupp, R. AU - Preusser, M. AU - Cohen-Jonathan-Moyal, E. PY - 2017 DA - 2017// TI - European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30194-8 DO - 10.1016/S1470-2045(17)30194-8 ID - Weller2017 ER - TY - JOUR AU - Louis, D. N. AU - Perry, A. AU - Reifenberger, G. AU - Deimling, A. AU - Figarella-Branger, D. AU - Cavenee, W. K. PY - 2016 DA - 2016// TI - The 2016 World Health Organization classification of tumors of the central nervous system: a summary JO - Acta Neuropathol (Berl) VL - 131 UR - https://doi.org/10.1007/s00401-016-1545-1 DO - 10.1007/s00401-016-1545-1 ID - Louis2016 ER - TY - JOUR AU - Perizzolo, M. AU - Winkfein, B. AU - Hui, S. AU - Krulicki, W. AU - Chan, J. A. AU - Demetrick, D. J. PY - 2012 DA - 2012// TI - IDH mutation detection in formalin-fixed paraffin-embedded gliomas using multiplex PCR and single-base extension: IDH1/2 mutation detection by SNaPshot® JO - Brain Pathol VL - 22 UR - https://doi.org/10.1111/j.1750-3639.2012.00579.x DO - 10.1111/j.1750-3639.2012.00579.x ID - Perizzolo2012 ER - TY - JOUR AU - Isal, S. AU - Gauchotte, G. AU - Rech, F. AU - Blonski, M. AU - Planel, S. AU - Chawki, M. B. PY - 2018 DA - 2018// TI - A high 18F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II–III gliomas JO - Br J Radiol VL - 91 ID - Isal2018 ER - TY - JOUR AU - Verger, A. AU - Stoffels, G. AU - Bauer, E. K. AU - Lohmann, P. AU - Blau, T. AU - Fink, G. R. PY - 2018 DA - 2018// TI - Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status JO - Eur J Nucl Med Mol Imaging VL - 45 UR - https://doi.org/10.1007/s00259-017-3846-6 DO - 10.1007/s00259-017-3846-6 ID - Verger2018 ER - TY - JOUR AU - Kratochwil, C. AU - Combs, S. E. AU - Leotta, K. AU - Afshar-Oromieh, A. AU - Rieken, S. AU - Debus, J. PY - 2014 DA - 2014// TI - Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors JO - Neuro-Oncol. VL - 16 UR - https://doi.org/10.1093/neuonc/not199 DO - 10.1093/neuonc/not199 ID - Kratochwil2014 ER - TY - JOUR AU - Schwarzenberg, J. AU - Czernin, J. AU - Cloughesy, T. F. AU - Ellingson, B. M. AU - Pope, W. B. AU - Grogan, T. PY - 2014 DA - 2014// TI - Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1440 DO - 10.1158/1078-0432.CCR-13-1440 ID - Schwarzenberg2014 ER - TY - STD TI - Ye H, Wong K-P, Wardak M, Dahlbom M, Kepe V, Barrio JR, et al. Automated movement correction for dynamic PET/CT images: evaluation with phantom and patient data. Chen K, editor. PLoS ONE. 2014;9:e103745. ID - ref28 ER - TY - JOUR AU - Ceccon, G. AU - Lohmann, P. AU - Stoffels, G. AU - Judov, N. AU - Filss, C. P. AU - Rapp, M. PY - 2017 DA - 2017// TI - Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy JO - Neuro-Oncol. VL - 19 ID - Ceccon2017 ER - TY - JOUR AU - Benjamini, Y. AU - Hochberg, Y. PY - 1995 DA - 1995// TI - Controlling the false discovery rate: a practical and powerful approach to multiple testing JO - J R Stat Soc Ser B Methodol VL - 57 ID - Benjamini1995 ER - TY - JOUR AU - Fleischmann, D. F. AU - Unterrainer, M. AU - Bartenstein, P. AU - Belka, C. AU - Albert, N. L. AU - Niyazi, M. PY - 2017 DA - 2017// TI - 18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images? JO - J Neuro-Oncol VL - 132 UR - https://doi.org/10.1007/s11060-016-2366-8 DO - 10.1007/s11060-016-2366-8 ID - Fleischmann2017 ER - TY - JOUR AU - Pöpperl, G. AU - Kreth, F. W. AU - Herms, J. AU - Koch, W. AU - Mehrkens, J. H. AU - Gildehaus, F. J. PY - 2006 DA - 2006// TI - Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? JO - J Nucl Med VL - 47 ID - Pöpperl2006 ER - TY - JOUR AU - Pöpperl, G. AU - Kreth, F. W. AU - Mehrkens, J. H. AU - Herms, J. AU - Seelos, K. AU - Koch, W. PY - 2007 DA - 2007// TI - FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading JO - Eur J Nucl Med Mol Imaging VL - 34 UR - https://doi.org/10.1007/s00259-007-0534-y DO - 10.1007/s00259-007-0534-y ID - Pöpperl2007 ER - TY - JOUR AU - Lohmann, P. AU - Herzog, H. AU - Rota Kops, E. AU - Stoffels, G. AU - Judov, N. AU - Filss, C. PY - 2015 DA - 2015// TI - Dual-time-point O-(2-[18F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas JO - Eur Radiol VL - 25 UR - https://doi.org/10.1007/s00330-015-3691-6 DO - 10.1007/s00330-015-3691-6 ID - Lohmann2015 ER - TY - JOUR AU - Carideo, L. AU - Minniti, G. AU - Mamede, M. AU - Scaringi, C. AU - Russo, I. AU - Scopinaro, F. PY - 2018 DA - 2018// TI - 18F-DOPA uptake parameters in glioma: effects of patients’ characteristics and prior treatment history JO - Br J Radiol VL - 91 UR - https://doi.org/10.1259/bjr.20170847 DO - 10.1259/bjr.20170847 ID - Carideo2018 ER - TY - JOUR AU - Stegmayr, C. AU - Stoffels, G. AU - Kops, E. R. AU - Lohmann, P. AU - Galldiks, N. AU - Shah, N. J. PY - 2019 DA - 2019// TI - Influence of dexamethasone on O-(2-[18F]-fluoroethyl)-L-tyrosine uptake in the human brain and quantification of tumor uptake JO - Mol Imaging Biol VL - 21 UR - https://doi.org/10.1007/s11307-018-1221-z DO - 10.1007/s11307-018-1221-z ID - Stegmayr2019 ER - TY - JOUR AU - Beppu, T. AU - Terasaki, K. AU - Sasaki, T. AU - Sato, Y. AU - Tomabechi, M. AU - Kato, K. PY - 2016 DA - 2016// TI - MRI and 11C-methyl-L-methionine PET differentiate bevacizumab true responders after initiating therapy for recurrent glioblastoma JO - Clin Nucl Med VL - 41 UR - https://doi.org/10.1097/RLU.0000000000001377 DO - 10.1097/RLU.0000000000001377 ID - Beppu2016 ER - TY - JOUR AU - Beppu, T. AU - Sato, Y. AU - Sasaki, T. AU - Terasaki, K. AU - Yamashita, F. AU - Sasaki, M. PY - 2019 DA - 2019// TI - Comparisons between PET with 11C-methyl-L-methionine and arterial spin labeling perfusion imaging in recurrent glioblastomas treated with bevacizumab JO - Clin Nucl Med VL - 44 UR - https://doi.org/10.1097/RLU.0000000000002417 DO - 10.1097/RLU.0000000000002417 ID - Beppu2019 ER - TY - JOUR AU - Hutterer, M. AU - Nowosielski, M. AU - Putzer, D. AU - Waitz, D. AU - Tinkhauser, G. AU - Kostron, H. PY - 2011 DA - 2011// TI - O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.110.086645 DO - 10.2967/jnumed.110.086645 ID - Hutterer2011 ER - TY - JOUR AU - Galldiks, N. AU - Rapp, M. AU - Stoffels, G. AU - Fink, G. R. AU - Shah, N. J. AU - Coenen, H. H. PY - 2013 DA - 2013// TI - Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-012-2251-4 DO - 10.1007/s00259-012-2251-4 ID - Galldiks2013 ER - TY - JOUR AU - Verger, A. AU - Metellus, P. AU - Sala, Q. AU - Colin, C. AU - Bialecki, E. AU - Taieb, D. PY - 2017 DA - 2017// TI - IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3668-6 DO - 10.1007/s00259-017-3668-6 ID - Verger2017 ER - TY - JOUR AU - Cicone, F. AU - Carideo, L. AU - Scaringi, C. AU - Arcella, A. AU - Giangaspero, F. AU - Scopinaro, F. PY - 2019 DA - 2019// TI - 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma JO - Ann Nucl Med VL - 33 UR - https://doi.org/10.1007/s12149-018-01328-3 DO - 10.1007/s12149-018-01328-3 ID - Cicone2019 ER - TY - STD TI - Zaragori T, Guedj E, Verger A. Is IDH mutation status associated with 18 F-FDopa PET uptake? Ann Nucl Med. 2020:1–2. ID - ref43 ER - TY - STD TI - Cicone F, Carideo L, Scaringi C, Minniti G. Reply to Zaragori et al.: “Is IDH mutation status associated with 18 F-FDopa PET uptake.”. Ann Nucl Med. 2020:1–2. ID - ref44 ER - TY - JOUR AU - Hoffman, J. M. AU - Melega, W. P. AU - Hawk, T. C. AU - Grafton, S. C. AU - Luxen, A. AU - Mahoney, D. K. PY - 1992 DA - 1992// TI - The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography JO - J Nucl Med VL - 33 ID - Hoffman1992 ER -